Top Bears Reasons To Sell — Vote below!

Add a New Bears Reason

Company: Baxter International (BAX)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
1 votes

  Recall of infusion pumps

The recalling of thousands of COLLEAGUE and SYNDEO PCA infusion pumps by the FDA has cost Baxter over $170 million from 2005 - 2006.

(100 character max) Cancel
0%
agree
1 votes

  Executive compensation

Baxter pays it executives generously with money that could be invested towards increasing the firm's growth.

(100 character max) Cancel
0%
agree
2 votes

  Broader impact of infusion pump woes

The infusion pump woes could have a broader impact on the Baxter brand name and impact sales in other segments if the problem is not resolved soon.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki